591 related articles for article (PubMed ID: 35061214)
1. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo F; Bragazzi NL; Nardone R; Trinka E
Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials.
Chen Y; Li W; Lu C; Gao X; Song H; Zhang Y; Zhao S; Cai G; Guo Q; Zhou D; Chen Y
EClinicalMedicine; 2024 Apr; 70():102513. PubMed ID: 38449838
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials.
Moseley B; Bourikas D; Dimova S; Elmoufti S; Borghs S
Adv Ther; 2024 Apr; 41(4):1746-1758. PubMed ID: 38356105
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis.
Mulheron S; Leahy TP; McStravick M; Doran R; Delanty N
Seizure; 2024 May; 118():80-90. PubMed ID: 38643679
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.
Yang Y; Shangguan Y; Wang X; Liu R; Shen Z; Tang M; Jiang G
Front Neurol; 2023; 14():1307296. PubMed ID: 38264091
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and tolerability of adjunctive brivaracetam in adult Asian patients with uncontrolled focal-onset seizures: A phase III randomized, double-blind, placebo-controlled trial.
Inoue Y; Tiamkao S; Zhou D; Cabral-Lim L; Lim KS; Lim SH; Tsai JJ; Moseley B; Wang L; Sun W; Hayakawa Y; Sasamoto H; Sano T; McClung C; Bass A
Epilepsia Open; 2024 Jun; 9(3):1007-1020. PubMed ID: 38576178
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Del Giovane C; Silvestrini M; Brigo F
CNS Drugs; 2020 Nov; 34(11):1105-1120. PubMed ID: 32851590
[TBL] [Abstract][Full Text] [Related]
9. A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
Roberti R; Di Gennaro G; Anzellotti F; Arnaldi D; Belcastro V; Beretta S; Boero G; Bonanni P; Canafoglia L; D'Aniello A; Dainese F; De Caro C; Di Gennaro G; Di Giacomo R; DiFrancesco JC; Dono F; Falcicchio G; Ferlazzo E; Foschi N; Franciotta S; Gambardella A; Giordano A; Iannone LF; Labate A; La Neve A; Lattanzi S; Leggio U; Liguori C; Maschio M; Nilo A; Operto FF; Pascarella A; Pauletto G; Renna R; Strigaro G; ; Russo E
Epilepsia; 2024 Feb; 65(2):456-472. PubMed ID: 38052481
[TBL] [Abstract][Full Text] [Related]
10. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.
Lee SK; Heo K; Kim SE; Lee SA; Elmoufti S; Laloyaux C; Hur B
Adv Ther; 2021 Jul; 38(7):4082-4099. PubMed ID: 34155568
[TBL] [Abstract][Full Text] [Related]
11. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
[TBL] [Abstract][Full Text] [Related]
12. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
[TBL] [Abstract][Full Text] [Related]
13. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
Privitera M; Richy FF; Schabert VF
Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis.
Wang H; Wang H; Liu Y; Zhao J; Niu X; Zhu L; Ma X; Zong Y; Huang Y; Zhang W; Han Y
CNS Drugs; 2023 Oct; 37(10):883-913. PubMed ID: 37589821
[TBL] [Abstract][Full Text] [Related]
15. Value of drug level concentrations of brivaracetam, lacosamide, and perampanel in care of people with epilepsy.
Hentschel M; Stoffel-Wagner B; Surges R; von Wrede R; Dolscheid-Pommerich RC
Epilepsia; 2024 Mar; 65(3):620-629. PubMed ID: 38158709
[TBL] [Abstract][Full Text] [Related]
16. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
[TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.
Ben-Menachem E; Baulac M; Hong SB; Cleveland JM; Reichel C; Schulz AL; Wagener G; Brandt C
Epilepsy Res; 2021 Feb; 170():106526. PubMed ID: 33461041
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Ryvlin P; Dimova S; Elmoufti S; Floricel F; Laloyaux C; Nondonfaz X; Biton V
Epilepsia; 2022 Aug; 63(8):2024-2036. PubMed ID: 35582748
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Lattanzi S; Trinka E; Russo E; Del Giovane C; Matricardi S; Meletti S; Striano P; Damavandi PT; Silvestrini M; Brigo F
Drugs; 2023 Oct; 83(15):1409-1424. PubMed ID: 37695433
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
